» Articles » PMID: 16337390

Pneumonectomy for Complex Aspergilloma: is It Still Dangerous?

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Pneumonectomy for complex aspergilloma is associated with high morbidity rates. This study aimed to improve the outcomes of this high-risk procedure by preventing postoperative complications.

Methods: Between April 1999 and December 2004, 25 patients underwent pulmonary resection for complex aspergilloma at our institution. Of these patients, 11 (44%) patients (9 males and 2 females) undergoing a pneumonectomy were reviewed in this study. Median age was 63 years (range, 36-71 years). Associated pulmonary diseases were cavities secondary to tuberculosis (n=6) and a post-lobectomy destroyed lung (n=5). All patients presented with symptoms, including hemoptysis (n=10) and purulent sputum (n=1). To minimize the risk of empyema and bronchopleural fistula, careful extrapleural dissection and bronchial stump reinforcement with a latissimus dorsi muscle flap were employed in all patients. Follow-up was completed on March 31, 2005.

Results: We performed six pneumonectomies (two right and four left) and five completion pneumonectomies (one right and four left). Operating time ranged from 361 to 781 min (median, 432 min). The median intraoperative blood loss was 1050 ml (range, 200-2910 ml). There was no operative mortality. No patient required re-exploration for postoperative hemorrhage. The major complications were empyema caused by anaerobic bacteria (n=1) and chylothorax (n=1). The treatment of both complications was successful. All patients were free from aspergillosis at the time of follow-up.

Conclusions: Pneumonectomy for symptomatic complex aspergilloma can be performed with no mortality and low morbidity. The favorable results of this potentially deleterious procedure hinge on the efforts to prevent postoperative complications.

Citing Articles

Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.

Tashiro M, Takazono T, Izumikawa K Ther Adv Infect Dis. 2024; 11:20499361241253751.

PMID: 38899061 PMC: 11186400. DOI: 10.1177/20499361241253751.


Aspergillus Coinfection in a Hydatid Cyst Cavity of Lung in an Immunocompetent Host: A Case Report and Review of Literature.

Adhikari A, Khanal S, Magar S, Thapa S, Khati S, Lamichhane R Case Rep Infect Dis. 2023; 2023:6975041.

PMID: 37485286 PMC: 10361833. DOI: 10.1155/2023/6975041.


Is there any change in disease presentation and surgical outcomes in patients with pulmonary aspergilloma? An evaluation of the time trend.

Pekcolaklar A, Citak N, Aksoy Y, Erdogu V, Metin M Turk Gogus Kalp Damar Cerrahisi Derg. 2022; 30(2):241-249.

PMID: 36168580 PMC: 9473594. DOI: 10.5606/tgkdc.dergisi.2022.21406.


Factors affecting survival after anatomical lung resection in pulmonary aspergilloma: Our 10-year single institution experience.

Bugra Sezen C, Aker C, Dogru M, Aksoy Y, Bilen S, Sonmezoglu Y Turk Gogus Kalp Damar Cerrahisi Derg. 2022; 30(1):92-100.

PMID: 35444855 PMC: 8990155. DOI: 10.5606/tgkdc.dergisi.2022.19982.


Video-assisted thoracoscopic surgery for invasive pulmonary fungal infection in haematology patients.

Ma H, Wang J, Ma X, Zheng S, Ma H, Ge J J Thorac Dis. 2019; 11(7):2839-2845.

PMID: 31463113 PMC: 6688021. DOI: 10.21037/jtd.2019.07.13.